Consolidated Statements Of Operations (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Net revenues:
Product revenue	$ 11,496,834	$ 11,461,531
Revenues, net	11,496,834	11,461,531
Costs and expenses:
Cost of goods sold	5,905,112	5,759,621
Marketing, general and administrative	5,718,267	6,015,932
Research and development	1,105,255	1,004,559
Goodwill Impairment	0
Total costs and expenses	12,728,634	12,780,112
Loss from operations	(1,231,800)	(1,318,581)
Other (expense) income:
Equity in Ocular Telehealth Management, LLC	14,415	7,491
Other Nonoperating Income (Expense)	78,004	7,491
Interest income	246	113
Interest expense	(79,479)	(339,393)
Total other (expense) income	(1,229)	(331,789)
Net loss from continuing operations before taxes	(1,233,029)	(1,651,000)
Net (loss) from continuing operations	(1,233,029)	(1,650,370)
Net income from discontinued operations	3,857,498	(4,294,427)
Discontinued Operation, Tax Effect of Discontinued Operation	(80,000)	0
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	3,937,498	(4,294,427)
Net loss	$ 2,624,469	$ (5,944,797)
Basic:
Continuing operations	$ (0.16)	$ (0.22)
Discontinued operations	$ 0.51	$ (0.57)
Net income (loss)	$ 0.35	$ (0.79)
Diluted:
Continuing operations	$ (0.16)	$ (0.22)
Discontinued operations	$ 0.51	$ (0.57)
Net income (loss)	$ 0.35	$ (0.79)
Weighted average shares - basic	7,526,430	7,526,430
Weighted average shares - diluted	7,526,430	7,526,430